Emerging trends of therapy related myeloid neoplasms following modern cancer therapeutics in the United States

Clonal hematopoiesis (CH) is a risk factor for the development of therapy-related myelodysplastic syndromes (tMDS) and acute myeloid leukemia (tAML). Adoption of targeted-immunotherapeutics since 2011, may alter the risk of CH progression to tMDS/AML. To study this, we evaluated risk of tMDS and tAM...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, Abhay, Herr, Megan M., Griffiths, Elizabeth A., Przespolewski, Amanda, Faber, Mark G., Mrad, Chebli, Wang, Eunice S., Hahn, Theresa, Thota, Swapna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8639740/
https://www.ncbi.nlm.nih.gov/pubmed/34857802
http://dx.doi.org/10.1038/s41598-021-02497-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8639740/
https://www.ncbi.nlm.nih.gov/pubmed/34857802
http://dx.doi.org/10.1038/s41598-021-02497-4

Ejemplares similares